igf 1-lr3 di repligen LONG®R3 IGF-I Liquid LR3 IGF-1 (Human), Recombinant Protein,

It is the only GHRH analog with FDA-recognized studies specifically demonstrating its ability to reduce visceral adipose tissue (VAT) the dangerous fat that surrounds abdominal organs and is associated with cardiovascular disease, insulin resistance, and metabolic syndrome

Both options have limitations

Mechanistic Research Perspective Investigation of intracellular signaling pathway modulation Analysis of receptor-mediated peptide interaction mechanisms Evaluation of growth factor responsiveness in cellular systems Gene transcription and molecular regulation research Integration into mitochondrial ATP production and metabolic pathway studies Primary Research Applications Cell Biology and Regenerative Models: Used in controlled cellular models to study signalling behaviour, adaptive responses, and peptide-driven molecular communication

Targets the GHS-R1a (ghrelin) receptor Same receptor as ghrelin, located in the pituitary and hypothalamus

Both peptides are discussed for recovery support, but they work differently